153 related articles for article (PubMed ID: 9276153)
1. Pharmacological characterization of nociceptin receptor: an in vitro study.
Calò G; Rizzi A; Bodin M; Neugebauer W; Salvadori S; Guerrini R; Bianchi C; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):713-8. PubMed ID: 9276153
[TBL] [Abstract][Full Text] [Related]
2. A new selective antagonist of the nociceptin receptor.
Guerrini R; Calo G; Rizzi A; Bigoni R; Bianchi C; Salvadori S; Regoli D
Br J Pharmacol; 1998 Jan; 123(2):163-5. PubMed ID: 9489602
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of [Tyr1]nociceptin analogs: receptor binding and bioassay studies.
Varani K; Rizzi A; Calo G; Bigoni R; Toth G; Guerrini R; Gessi S; Salvadori S; Borea PA; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 1999 Sep; 360(3):270-7. PubMed ID: 10543428
[TBL] [Abstract][Full Text] [Related]
4. The mouse vas deferens: a pharmacological preparation sensitive to nociceptin.
Calò G; Rizzi A; Bogoni G; Neugebauer V; Salvadori S; Guerrini R; Bianchi C; Regoli D
Eur J Pharmacol; 1996 Sep; 311(1):R3-5. PubMed ID: 8884244
[TBL] [Abstract][Full Text] [Related]
5. Effects of Ro 64-6198 in nociceptin/orphanin FQ-sensitive isolated tissues.
Rizzi D; Bigoni R; Rizzi A; Jenck F; Wichmann J; Guerrini R; Regoli D; Calo G
Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):551-5. PubMed ID: 11383716
[TBL] [Abstract][Full Text] [Related]
6. In vitro pharmacological profile of peptide III-BTD: a novel ligand for nociceptin/orphanin FQ and opioid receptors.
Bigoni R; Rizzi A; Rizzi D; Becker JA; Kieffer BL; Simonin F; Regoli D; Calo G
Life Sci; 2000 Dec; 68(2):233-9. PubMed ID: 11191640
[TBL] [Abstract][Full Text] [Related]
7. Further studies on nociceptin-related peptides: discovery of a new chemical template with antagonist activity on the nociceptin receptor.
Guerrini R; Caló G; Bigoni R; Rizzi A; Varani K; Toth G; Gessi S; Hashiba E; Hashimoto Y; Lambert DG; Borea PA; Tomatis R; Salvadori S; Regoli D
J Med Chem; 2000 Jul; 43(15):2805-13. PubMed ID: 10956188
[TBL] [Abstract][Full Text] [Related]
8. Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies.
Bigoni R; Giuliani S; Calo' G; Rizzi A; Guerrini R; Salvadori S; Regoli D; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):160-7. PubMed ID: 10208302
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of [Phe1psi(CH2-NH)Gly2]nociceptin(1-13)NH2 in rat brain, rat vas deferens and CHO cells expressing recombinant human nociceptin receptors.
Okawa H; Nicol B; Bigoni R; Hirst RA; Calo G; Guerrini R; Rowbotham DJ; Smart D; McKnight AT; Lambert DG
Br J Pharmacol; 1999 May; 127(1):123-30. PubMed ID: 10369464
[TBL] [Abstract][Full Text] [Related]
10. [Arg(14),Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies.
Rizzi D; Rizzi A; Bigoni R; Camarda V; Marzola G; Guerrini R; De Risi C; Regoli D; Calo' G
J Pharmacol Exp Ther; 2002 Jan; 300(1):57-63. PubMed ID: 11752097
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of [Nphe1]-NC-(1-13)-NH2, a pure and selective nociceptin/orphanin FQ receptor antagonist.
Guerrini R; Calo' G; Bigoni R; Rizzi D; Regoli D; Salvadori S
J Pept Res; 2001 Mar; 57(3):215-22. PubMed ID: 11298922
[TBL] [Abstract][Full Text] [Related]
12. In vitro agonist effects of nociceptin and [Phe(1)psi(CH(2)-NH)Gly(2)]nociceptin(1-13)NH(2) in the mouse and rat colon and the mouse vas deferens.
Menzies JR; Glen T; Davies MR; Paterson SJ; Corbett AD
Eur J Pharmacol; 1999 Dec; 385(2-3):217-23. PubMed ID: 10607879
[TBL] [Abstract][Full Text] [Related]
13. Orphanin FQ has an inhibitory effect on the guinea pig ileum and the mouse vas deferens.
Zhang G; Murray TF; Grandy DK
Brain Res; 1997 Oct; 772(1-2):102-6. PubMed ID: 9406961
[TBL] [Abstract][Full Text] [Related]
14. In vitro characterization of J-113397, a non-peptide nociceptin/orphanin FQ receptor antagonist.
Bigoni R; Calo' G; Rizzi A; Guerrini R; De Risi C; Hashimoto Y; Hashiba E; Lambert DG; Regoli D
Naunyn Schmiedebergs Arch Pharmacol; 2000 May; 361(5):565-8. PubMed ID: 10832612
[TBL] [Abstract][Full Text] [Related]
15. Opioid receptor agonistic characteristics of mitragynine pseudoindoxyl in comparison with mitragynine derived from Thai medicinal plant Mitragyna speciosa.
Yamamoto LT; Horie S; Takayama H; Aimi N; Sakai S; Yano S; Shan J; Pang PK; Ponglux D; Watanabe K
Gen Pharmacol; 1999 Jul; 33(1):73-81. PubMed ID: 10428019
[TBL] [Abstract][Full Text] [Related]
16. Effects of nociceptin and endomorphin 1 on the electrically stimulated human vas deferens.
Bigoni R; Calo G; Guerrini R; Strupish JW; Rowbotham DJ; Lambert DG
Br J Clin Pharmacol; 2001 Apr; 51(4):355-8. PubMed ID: 11318773
[TBL] [Abstract][Full Text] [Related]
17. Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist.
Calo' G; Guerrini R; Bigoni R; Rizzi A; Bianchi C; Regoli D; Salvadori S
J Med Chem; 1998 Aug; 41(18):3360-6. PubMed ID: 9719588
[TBL] [Abstract][Full Text] [Related]
18. Nociceptin inhibits capsaicin-sensitive contraction to mesenteric nerve stimulation in the guinea-pig isolated ileum.
Sugimori S; Kadowaki M; Yoneda S; Yamanouchi M; Nakano H; Takaki M
Auton Neurosci; 2000 Dec; 86(1-2):65-9. PubMed ID: 11269926
[TBL] [Abstract][Full Text] [Related]
19. Determination of the receptor selectivity of opioid agonists in the guinea-pig ileum and mouse vas deferens by use of beta-funaltrexamine.
Hayes AG; Sheehan MJ; Tyers MB
Br J Pharmacol; 1985 Dec; 86(4):899-904. PubMed ID: 3000501
[TBL] [Abstract][Full Text] [Related]
20. N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands.
Guerrini R; Caló G; Lambert DG; Carrá G; Arduin M; Barnes TA; McDonald J; Rizzi D; Trapella C; Marzola E; Rowbotham DJ; Regoli D; Salvadori S
J Med Chem; 2005 Mar; 48(5):1421-7. PubMed ID: 15743186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
